Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study.
Semin Oncol
; 28(3 Suppl 10): 50-6, 2001 Jun.
Article
em En
| MEDLINE
| ID: mdl-11510034
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Limite:
Adult
/
Aged
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2001
Tipo de documento:
Article